AbbVie
ABBV
#31
Rank
โ‚น42.496 T
Marketcap
โ‚น24,053
Share price
0.38%
Change (1 day)
52.48%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น578.09 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น61.16 Billion. , an increase over its 2024 earnings that were of โ‚น351.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น623.94 B77.53%
2024 โ‚น351.45 B-40.54%
2023 โ‚น591.12 B-53.62%
2022 โ‚น1.274 T3.76%
2021 โ‚น1.228 T282.25%
2020 โ‚น321.38 B-59.67%
2019 โ‚น796.93 B62.13%
2018 โ‚น491.53 B-32.74%
2017 โ‚น730.81 B-1.99%
2016 โ‚น745.66 B18.65%
2015 โ‚น628.48 B180.5%
2014 โ‚น224.06 B-55.57%
2013 โ‚น504.30 B-6.86%
2012 โ‚น541.46 B56.05%
2011 โ‚น346.96 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.001 T 60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.943 T 371.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น859.44 B 37.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น153.50 B-75.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น926.60 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น907.68 B 45.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.386 T 122.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น946.87 B 51.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น75.55 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA